Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

CDNetworks Rapidly Expanded Its Global Scrubbing Center Network in 2023, Offering Sub-Second Scrubbing Service with Over 15 Tbps Capacity




With over 10 new scrubbing centers opened in 2023, CDNetworks continues to accelerate deployment of scrubbing centers to offer best-in-class availability and resilience.

SINGAPORE, March 6, 2024 /PRNewswire/ — CDNetworks, the APAC-leading network to deliver edge as a service, today announced it rapidly expanded its global network of scrubbing centers in 2023 to help organizations boost availability, enhance resiliency, and secure the digital experience. Offering sub-second scrubbing services, with a capacity exceeding 15 Tbps, this rapid expansion is ideally suited to help organizations cope with the increasingly severe DDoS attacks and more complex compliance concerns. 

According to CDNetworks’ latest State of Web Application and API Protection Report, the frequency of DDoS attacks is significantly increasing, with TB-level attacks becoming more common. The report also highlights a shift in the variety of attack methods being employed, indicating that organizations need to adopt unprecedented measures and pay increasing attention to DDoS protection. Additionally, the growing emphasis on compliance with global regulatory standards is shaping the cybersecurity strategies of companies worldwide. These regulatory mandates necessitate the adoption of localized scrubbing centers, making them an essential component of a robust cybersecurity posture. In this context, the localization of extensive scrubbing center network becomes even more important when it comes to minimizing your risk of a DDoS attack.

“As DDoS attack methods undergo profound changes, the role of local scrubbing centers will become more prominent. Local scrubbing centers will become a critical safeguard for an increasing number of low-latency services while delivering a safe and secure experience to end-users. At the same time, local scrubbing centers will help organizations deal with malicious traffic without allowing data to leave its country of origin. This two-fold approach not only enhances the protection capabilities of an organization’s services, but also satisfies the requirements of compliance regulations,” said Doyle Deng, Head of Global Marketing and Product at CDNetworks.

Doyle further explained, “These factors are the motivations for accelerating the deployment of our scrubbing center network in 2023. This is especially true when it comes to emerging markets, such as Singapore, Thailand, Vietnam, Indonesia, and the Philippines. This expansion further buttressed our global scrubbing resources, meeting the evolving needs of customer businesses. Currently, we continue to expand our local scrubbing centers in South and Southeast Asia, Middle East, South America, and other regions. This ongoing expansion will reinforce our sub-second-level scrubbing services, assisting with the delivery of unparalleled world-class security without impacting latencies and end-user experiences.

Scrubbing Centers Built in 2023

  • Surabaya, Indonesia
  • Cebu City, Philippines 
  • Manila, Philippines
  • Singapore (*2 Centers)
  • Bangkok, Thailand (*3 Centers)
  • Ho Chi Minh City, Vietnam (*2 Centers)
  • Paris, France
  • Montreal, Canada

With the official opening of the scrubbing center in Montreal, Canada, at the end of last year, CDNetworks now has more than 20 scrubbing centers globally. These strategic expansions will enhance CDNetworks’ ability to assist businesses worldwide to mitigate diverse DDoS attacks quickly and effectively.

Since 2021, CDNetworks has significantly increased its investment in cloud security, having launched a number of cloud security products including its WAAP solution. This commitment to advancing cloud security technology has enabled CDNetworks to stand at the forefront of defending against sophisticated cyberthreats. Over the years, CDNetworks has successfully helped organizations in Banking, financial services, and insurance (BFSI), gaming, software information services, and other industries to withstand repeated large-scale DDoS attacks multiple times, continuously earning regular praise and recognition in the industry.

Noteworthy DDoS Mitigation Successes by CDNetworks:

  • In the BFSI sector, we showcased our exceptional defensive capabilities by successfully neutralizing a 1.025 Tbps DDoS attack in January 2024, ensuring uninterrupted business continuity for our client.
  • Within the gaming industry, our expertise in handling frequent volumetric DDoS attacks was proven, as we assisted several companies to overcome challenges. These achievements included repelling a 1.05 Tbps attack in October 2023, a 1.72 Tbps attack in January 2023, and a 2.09 Tbps attack in January 2022.
  • In the software and information services sectors, we safeguarded a well-known multinational corporation from a massive 34.7 million RPS DDoS attack in April 2022, underlining our capability to protect global organizations from sophisticated cyberthreats.

For the latest information about CDNetworks’ scrubbing center network, please visit our Flood Shield product page for new updates.

About CDNetworks

As the APAC-leading network with over 2,800 global Points of Presence and more than 20 years of technology experience, CDNetworks embraces the new era of Edge and takes it to the next level by using the Edge as a service to deliver the fastest and most secure digital experiences to end users. Our diverse products and services include web performance, media delivery, cloud security, zero trust security, and colocation services – all of which are uniquely designed to spur business innovation. To learn more, visit and follow us on LinkedIn.

Media Contact
CDNetworks Co. Ltd
[email protected]

Logo –

Cision View original content:

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024




STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision,c3956826

The following files are available for download:

Invitation to presentation of EQT AB’s Q1 Announcement 2024,c3285895

EQT AB Group


View original content:

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs



  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo –

Cision View original content to download multimedia:

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update




VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (, a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit and connect with us on X and LinkedIn.


Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo –

Cision View original content:

Continue Reading